(BEI) Beiersdorf - Overview
Stock: Skin Care, Adhesive Tapes, Body Care, Self-Adhesive
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.84% |
| Yield on Cost 5y | 1.13% |
| Yield CAGR 5y | 9.33% |
| Payout Consistency | 92.7% |
| Payout Ratio | 18.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 19.8% |
| Relative Tail Risk | -0.89% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.95 |
| Alpha | -20.27 |
| Character TTM | |
|---|---|
| Beta | -0.123 |
| Beta Downside | -0.208 |
| Drawdowns 3y | |
|---|---|
| Max DD | 40.21% |
| CAGR/Max DD | -0.06 |
Description: BEI Beiersdorf December 19, 2025
Beiersdorf Aktiengesellschaft (XETRA:BEI) manufactures and distributes consumer goods across Europe, the United States, Africa, Asia, and Australia, operating through two distinct segments: Consumer Business, which focuses on skin- and body-care products, and Tesa Business, which supplies adhesive tapes and self-adhesive solutions to industrial, craft, and consumer markets.
The company’s portfolio includes well-known brands such as NIVEA, Eucerin, La Prairie, Hansaplast, Coppertone, Labello, and tesa, serving end-consumers as well as sectors like automotive, consumer electronics, printing & packaging, and electrical systems. Beiersdorf also runs a direct-to-consumer online store to complement its traditional distribution channels.
In FY 2023 Beiersdorf reported revenue of approximately €9.5 billion, with organic growth of around 5 % driven largely by premium skin-care demand in North America and Asia-Pacific. The Consumer Business segment contributed roughly 80 % of total sales and posted an adjusted EBIT margin of 13 %, while the Tesa Business segment delivered a stable 10 % margin despite modest volume growth. Key economic drivers include rising disposable income in emerging markets, inflation-sensitive pricing pressure, and supply-chain constraints affecting raw-material costs for adhesives.
For a deeper quantitative view, the ValueRay platform provides a granular breakdown of BEI’s valuation metrics.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 1.34b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 6.64 > 1.0 |
| NWC/Revenue: 17.00% < 20% (prev 16.96%; Δ 0.04% < -1%) |
| CFO/TA 0.16 > 3% & CFO 2.06b > Net Income 1.34b |
| Net Debt (-1.17b) to EBITDA (2.79b): -0.42 < 3 |
| Current Ratio: 1.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (223.1m) vs 12m ago -1.65% < -2% |
| Gross Margin: 58.20% > 18% (prev 0.57%; Δ 5763 % > 0.5%) |
| Asset Turnover: 131.8% > 50% (prev 106.7%; Δ 25.11% > 0%) |
| Interest Coverage Ratio: 36.44 > 6 (EBITDA TTM 2.79b / Interest Expense TTM 56.0m) |
Altman Z'' 6.71
| A: 0.22 (Total Current Assets 6.65b - Total Current Liabilities 3.77b) / Total Assets 12.92b |
| B: 0.67 (Retained Earnings 8.69b / Total Assets 12.92b) |
| C: 0.16 (EBIT TTM 2.04b / Avg Total Assets 12.86b) |
| D: 1.89 (Book Value of Equity 8.42b / Total Liabilities 4.44b) |
| Altman-Z'' Score: 6.71 = AAA |
Beneish M -3.19
| DSRI: 0.83 (Receivables 2.35b/2.30b, Revenue 16.95b/13.66b) |
| GMI: 0.97 (GM 58.20% / 56.70%) |
| AQI: 0.81 (AQ_t 0.27 / AQ_t-1 0.34) |
| SGI: 1.24 (Revenue 16.95b / 13.66b) |
| TATA: -0.06 (NI 1.34b - CFO 2.06b) / TA 12.92b) |
| Beneish M-Score: -3.19 (Cap -4..+1) = AA |
What is the price of BEI shares?
Over the past week, the price has changed by +2.84%, over one month by +8.71%, over three months by +10.74% and over the past year by -17.75%.
Is BEI a buy, sell or hold?
What are the forecasts/targets for the BEI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 116.9 | 13.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 100.2 | -3% |
BEI Fundamental Data Overview February 03, 2026
P/E Trailing = 23.3114
P/E Forward = 21.4133
P/S = 2.2733
P/B = 2.5887
P/EG = 3.0145
Revenue TTM = 16.95b EUR
EBIT TTM = 2.04b EUR
EBITDA TTM = 2.79b EUR
Long Term Debt = 132.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 192.0m EUR (from shortTermDebt, last quarter)
Debt = 324.0m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.17b EUR (from netDebt column, last quarter)
Enterprise Value = 19.54b EUR (20.38b + Debt 324.0m - CCE 1.17b)
Interest Coverage Ratio = 36.44 (Ebit TTM 2.04b / Interest Expense TTM 56.0m)
EV/FCF = 16.72x (Enterprise Value 19.54b / FCF TTM 1.17b)
FCF Yield = 5.98% (FCF TTM 1.17b / Enterprise Value 19.54b)
FCF Margin = 6.89% (FCF TTM 1.17b / Revenue TTM 16.95b)
Net Margin = 7.93% (Net Income TTM 1.34b / Revenue TTM 16.95b)
Gross Margin = 58.20% ((Revenue TTM 16.95b - Cost of Revenue TTM 7.09b) / Revenue TTM)
Gross Margin QoQ = 59.37% (prev 57.69%)
Tobins Q-Ratio = 1.51 (Enterprise Value 19.54b / Total Assets 12.92b)
Interest Expense / Debt = 4.63% (Interest Expense 15.0m / Debt 324.0m)
Taxrate = 31.33% (128.0m / 408.5m)
NOPAT = 1.40b (EBIT 2.04b * (1 - 31.33%))
Current Ratio = 1.76 (Total Current Assets 6.65b / Total Current Liabilities 3.77b)
Debt / Equity = 0.04 (Debt 324.0m / totalStockholderEquity, last quarter 8.47b)
Debt / EBITDA = -0.42 (Net Debt -1.17b / EBITDA 2.79b)
Debt / FCF = -1.00 (Net Debt -1.17b / FCF TTM 1.17b)
Total Stockholder Equity = 8.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.45% (Net Income 1.34b / Total Assets 12.92b)
RoE = 15.95% (Net Income TTM 1.34b / Total Stockholder Equity 8.42b)
RoCE = 23.85% (EBIT 2.04b / Capital Employed (Equity 8.42b + L.T.Debt 132.0m))
RoIC = 16.61% (NOPAT 1.40b / Invested Capital 8.44b)
WACC = 5.42% (E(20.38b)/V(20.71b) * Re(5.46%) + D(324.0m)/V(20.71b) * Rd(4.63%) * (1-Tc(0.31)))
Discount Rate = 5.46% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.83%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈823.8m ; Y1≈1.02b ; Y5≈1.73b
Fair Price DCF = 232.9 (EV 50.40b - Net Debt -1.17b = Equity 51.56b / Shares 221.4m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 17.51 | EPS CAGR: 20.96% | SUE: -0.95 | # QB: 0
Revenue Correlation: 37.49 | Revenue CAGR: -8.76% | SUE: 0.04 | # QB: 0
EPS next Year (2026-12-31): EPS=4.71 | Chg30d=-0.039 | Revisions Net=-10 | Growth EPS=+6.6% | Growth Revenue=+3.3%